Acute lymphoblastic leukemia with coexpression of CD56 and CD57: Case report

Pediatric Hematology and Oncology

Volumn 21, Issue 7, 2004, Pages 677-682

  Matsubara, Kousaku ^a   Yura, Kazuo ^a   Hirata, Takuya ^a   Nigami, Hiroyuki ^a   Harigaya, Hidekazu ^a   Nozaki, Hideo ^a   Fukaya, Takashi ^a   Baba, Kunizo ^a  

^a NISHI KOBE MEDICAL CENTER   (Japan)

Author keywords

Acute lymphoblastic leukemia; CD56; CD57; Natural killer cell

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE PANCREATITIS; ARTICLE; BACKACHE; BLAST CELL; BLOOD CHEMISTRY; BONE MARROW BIOPSY; CASE REPORT; CELL STRUCTURE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; FEVER; GENE REARRANGEMENT; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTERSTITIAL PNEUMONIA; LEUKEMIA CELL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MALAISE; NEUTROPHIL; PALLOR; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; THROMBOCYTE COUNT; TREATMENT OUTCOME; VIRUS INFECTION;

ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD57; B-LYMPHOCYTES; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE;

EID: 5044234324     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010490501105     Document Type: Article

References (17)

1. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood. 1995;85:2654-2670.
2. Ichinohasama R, Endoh K, Ishizawa K, Okuda M, Kameoka J, Meguro K, Myers J, Kadin ME, Mori S, Sawai T. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin. Cancer. 1996;77:2592-2903.
3. Ino T, Tuzuki M, Okamoto M, Shamoto M, Hirano M. Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor. Ann Hematol. 1999;78:43-47.
4. - myeloid/natural killer cell acute leukemia: a previously unrecognized from of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.
5. Suzuki R, Yamamoto K, Seto M, et al. CD7 and CD56 myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417-2428.
6. Ikushima S, Yoshihira T, Matsumura T, et al. Expression of CD56/NCAM on hematopoietic malignant cells: a useful marker for acute monocytic and megakaryocytic leukemias. Int J Hematol. 1991;54:395-403.
7. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung HMC. CD56 (NKH-1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Human Pathol. 1992;23:798-804.
8. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the natural cell adhesion molecule (CD56). Leukemia. 1994;8:823-826.
9. Paietta E, Neuberg D, Richards S, et al, and the Eastern Cooperative Oncology Group. Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. Am J Hematol. 2001;66:189-196.
10. Brunning RD, Matutes E, Borowitz M, et al. Acute leukaemias of ambiguous lineage. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetic of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:106-107.
11. + acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood. 1989;73:1000-1015.
12. Lenormand B, Vannier JP, Bene MC, et al, and the Groupe D'Etud Immunologique des Leucémies. CD2+ CD19+ acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Br J Haematol. 1993;83:580-583.
13. Manabe A, Mori T, Ebihara Y, et al. Characterization of leukemic cells in CD2/CD19 double positive acute lymphoblastic leukemia. Int J Hematol. 1998;67:45-52.
14. Fey MF, Tobler A, Stadelmann B, et al. Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemia. Eur J Haematol. 1990;45:215-222.
15. Reis MD, Griesser H, Mak TW. T cell receptor and immunoglobulin genes in hematologic malignancies. Tumor Biol. 1990;11(Suppl I):59-77.
16. Liang R, Chan VV, Chan TK, Chiu E, Todd D. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias. Acta Haematol. 1991;85:71-75.
17. Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoeven M-AJ, van Wering ER, van Dongen JJM. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-δ gene rearrangements in acute lymphoblastic leukemia. Blood. 1993;82:3063-3074.